AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

NTD

Published November 13, 2026 · Updated November 14, 2026

RFK Jr. Commits $4.9 Million to Study Ibogaine for Veterans' PTSD - NTD News

Read the full story at NTD

The Trump administration is putting millions to study ibogaine as a potential Post Traumatic Stress Disorder treatment for military veterans.

Post on X

Share this story

Surfaced by this Google Alert

Ibogaine